Skip to content

Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort

Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04885556
Enrollment
30
Registered
2021-05-13
Start date
2021-04-05
Completion date
2021-09-15
Last updated
2021-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Vaginoses, Dyspareunia, Female Sexual Dysfunction, Vaginal Discharge, Vaginitis

Keywords

vaginal discharge, dripping, vaginal odor

Brief summary

Previous research has shown that semen deposition in the vagina after intercourse leads to dripping, discomfort, and vaginal odor. This study is evaluating a hygiene device designed to be inserted into the vagina after intercourse to absorb semen deposited into the vaginal canal to determine if there is a reduction in dripping and odor, and to determine the amount of fluids absorbed.

Detailed description

Despite the significant number of sexual dysfunctions in women, physicians often avoid discussing these concerns in the office setting. With recent research on the role of the pelvic floor, and recently approved medical therapies for hypoactive sexual desire disorder, physicians have begun to adapt to questioning patients about libido and pain-related sexual dysfunctions. However, pain-related sexual questionnaires often focus on insertional and penetrational dyspareunia, without asking about discomfort minutes, hours, or even the day following sexual intercourse. One common compliant in ambulatory sexual medicine clinics is the bothersome dripping, odor, and discomfort women experience after sexual activity when no condom is used, and when intravaginal ejaculation occurs. Previous studies have shown the effects of semen on alterations in the vaginal flora. These changes contribute to a multitude of clinical complaints and diagnoses, including malodor, continuous discharge after intercourse, and bacterial vaginosis (BV). The exposure of semen changes the vaginal flora by increasing the pH levels, in turn altering the bacterial growth pattern. This implies the persistent presence of semen in the vagina may be one of the causes of malodor and development of BV. Chvapil utilized gas chromatography and demonstrated that the longer period of time semen was present in the vagina, the more likely it resulted in a strong and unattractive vaginal odor. Gallo showed that an incidental diagnosis of BV was correlated with detection of sperm on gram stain, and frequent coitus with or without condom use. The investigator's goal in this study is to evaluate a novel postcoital consumer health product and its effects on the complaints of continuous seepage of semen and vaginal odor after intercourse.

Interventions

DEVICETampon-like device for absorption of sexual fluids

Subjects will insert a tampon-like device to absorb sexual fluids after intercourse

Sponsors

Atlantic Health System
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Subjects to be placed into one of two study groups, 1) immediate use and 2) 1 hour use

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Heterosexual * Age 25-50 * Has used tampons in the past 5 years * Sexually active (vaginal intercourse, minimum once per week) * Answered moderate to severe to being bothered by dripping/discomfort on Patient Global Impression of Severity (PGI-S) questionnaire on minutes, hours, or following day * Willing and able to use product * Understands, reads, writes, and speaks English

Exclusion criteria

* Pregnant * Currently using condoms * Unable to use device due to poor motor function * Chronic disease which makes prone to infection (diabetes, autoimmune) * Recurrent yeast infections * Recurrent Urinary tract infection (UTI) (\>2 within the past year) * Diagnosis of pelvic organ prolapse (Stage II or greater) * Previous pelvic or vaginal surgery which, in the opinion of the investigator, may prevent proper use of product * Unable to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Patient Global Impression of Improvement (PGI-I)within 1 hour of use of productValidated Questionnaire
Weight of Investigational Devicewithin 1 hour of use of productProduct weight (amount of fluid absorbed)

Countries

United States

Contacts

Primary ContactCynthia Evaniecki
cevaniecki@gsunj.com973-537-5557

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026